Filing Details

Accession Number:
0001453687-21-000081
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-03 16:30:28
Reporting Period:
2021-06-01
Accepted Time:
2021-06-03 16:30:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1453687 Selecta Biosciences Inc SELB Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1760229 Carsten Brunn C/O Selecta Biosciences, Inc.
65 Grove Street
Watertown MA 02472
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-01 10,938 $0.00 227,764 No 4 M Direct
Common Stock Disposition 2021-06-02 4,806 $4.38 222,958 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2021-06-01 10,938 $0.00 10,938 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
65,625 No 4 M Direct
Footnotes
  1. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
  2. The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $4.34 to $4.385. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Each restricted stock unit represents a contingent right to receive one share of common stock.
  4. This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date.